These projects take advantage of the laboratory's expertise in studying molecular interactions and molecular structure. For aspect (1) indicated above, we have developed a strategy for generating disulfide-trapped peptide/MHC-I molecules and have expressed, refolded, purified, and crystallized several of these. In particular, we have examined H2-Dd molecules in which a residue in the binding cleft has been mutated to cysteine and have refolded these with peptides containing cysteine in appropriate positions. X-ray crystallographic structures of these confirm that the disulfide trapped peptides are stably fixed in the peptide binding groove. Versions of these produced with truncated peptides indicate that these molecules are peptide-stabilized in part of the peptide binding groove but are relaxed in the positions of truncation. Preliminary binding studies indicate that these molecules should allow mapping of sites of interaction with various cellular and viral chaperones. In addition, we are testing strategies for generating ultra-stable MHC molecules by introducing novel intrachain disulfide bonds. Several of these have been made, purified and are being examined in binding and structural analyses. For (2) above, in collaboration with the Coligan laboratory, we have examined the molecular interaction of the myeloid cell receptor CD300b with LPS by surface plasmon resonance. CD300b expression in mice enhances endotoxemia- and peritonitis-induced lethality related to signaling through CD300b, and further studies indicated the role of CD300b activation of the TLR4-CD14-TRIF mediated inflammatory responses. For (3) above, collaborative with the Berzofsky laboratory, we explored unique peptides generated as a result of vaccine immunization of mice in which cathepsin S sites were manipulated to alter cross-presentation. Our laboratory has examined the X-ray structure of several unique peptide/H2-Dd complexes. These structures explain the differential binding of the peptides generated, and explain the behavior of their respective tetramers in identifying CD8 T cell populations evoked by vaccination. For (4), carried out collaboratively with Mitsuo Honda, explores the CD8 T cell response to immunization of mice with recombinant BCG based vaccines that encode the Ag85B protein of M. tuberculosis. Several H2-Kd-restricted Ag85B peptides have been identified and we have crystallized and determined the X-ray structures of these. These structures explain that variant peptides can bind to MHC molecules like H2-Kd in novel conformations, and offer structural insight into cross-reactive and non-cross-reactive T cell populations primed by the new vaccines.

Project Start
Project End
Budget Start
Budget End
Support Year
25
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
Zip Code
Frey, Blake F; Jiang, Jiansheng; Sui, Yongjun et al. (2018) Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity. J Immunol 200:1853-1864
Margulies, David H (2018) How MHC molecules grab citrullinated peptides to foster rheumatoid arthritis. J Biol Chem 293:3252-3253
Voss, Oliver H; Murakami, Yousuke; Pena, Mirna Y et al. (2016) Lipopolysaccharide-Induced CD300b Receptor Binding to Toll-like Receptor 4 Alters Signaling to Drive Cytokine Responses that Enhance Septic Shock. Immunity 44:1365-78
Murakami, Y; Tian, L; Voss, O H et al. (2014) CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition. Cell Death Differ 21:1746-57
Subramanian, Naeha; Natarajan, Kannan; Clatworthy, Menna R et al. (2013) The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 153:348-61
Norcross, Michael A; Luo, Shen; Lu, Li et al. (2012) Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. AIDS 26:F21-9
Revilleza, Maria Jamela; Wang, Rui; Mans, Janet et al. (2011) How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance. J Biomed Biotechnol 2011:724607
Tilahun, Mulualem E; Kwan, Alan; Natarajan, Kannan et al. (2011) Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB. PLoS One 6:e27203
Tilahun, Mulualem E; Rajagopalan, Govindarajan; Shah-Mahoney, Nalini et al. (2010) Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies. Infect Immun 78:2801-11
Tang, Xiaobin; Narayanan, Sriram; Peruzzi, Giovanna et al. (2009) A single residue, arginine 65, is critical for the functional interaction of leukocyte-associated inhibitory receptor-1 with collagens. J Immunol 182:5446-52

Showing the most recent 10 out of 13 publications